The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Treatment outcomes in older adolescent and young adult (AYA) patients with newly diagnosed AML.
J. A. Canner
No relevant relationships to disclose
T. A. Alonzo
No relevant relationships to disclose
J. Franklin
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
D. R. Freyer
No relevant relationships to disclose
A. S. Gamis
No relevant relationships to disclose
R. B. Gerbing
No relevant relationships to disclose
B. Lange
No relevant relationships to disclose
S. Meshinchi
No relevant relationships to disclose
W. G. Woods
No relevant relationships to disclose
J. P. Perentesis
No relevant relationships to disclose
J. Horan
No relevant relationships to disclose